Section
E79
Disorders of purine and pyrimidine metabolism
Hierarchy
Notes
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes 1
E79
-
Ataxia-telangiectasia (Q87.19)
- Q87.19 Other congenital malformation syndromes predominantly associated with short stature
-
Bloom's syndrome (Q82.8)
- Q82.8 Other specified congenital malformations of skin
-
Cockayne's syndrome (Q87.19)
- Q87.19 Other congenital malformation syndromes predominantly associated with short stature
- N20.0 Calculus of kidney
-
combined immunodeficiency disorders (D81.-)
- D81 Combined immunodeficiencies
-
Fanconi's anemia (D61.09)
- D61.09 Other constitutional aplastic anemia
- gout (M1A.-, M10.-)
-
orotaciduric anemia (D53.0)
- D53.0 Protein deficiency anemia
-
progeria (E34.8)
- E34.8 Other specified endocrine disorders
-
Werner's syndrome (E34.8)
- E34.8 Other specified endocrine disorders
- Q82.1 Xeroderma pigmentosum
- E34.5 Androgen insensitivity syndrome
-
congenital adrenal hyperplasia (E25.0)
- E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
-
hemolytic anemias attributable to enzyme disorders (D55.-)
- D55 Anemia due to enzyme disorders
- Q87.4 Marfan syndrome
-
5-alpha-reductase deficiency (E29.1)
- E29.1 Testicular hypofunction
- P70-P74 Transitory endocrine and metabolic disorders specific to newborn (P70-P74)